| Literature DB >> 23954946 |
Rosemary Hiscock1, Susan Murray, Leonie S Brose, Andy McEwen, Jo Leonardi Bee, Fiona Dobbie, Linda Bauld.
Abstract
BACKGROUND: Disadvantaged smokers are less likely to be successful when trying to stop smoking than more affluent smokers. In the UK, NHS Stop Smoking Services (SSS) provide a range of pharmacotherapy and behavioural support, delivered by advisors with a range of backgrounds. Whether the types of support provided and who provides it influence differences in quit rates amongst low SES smokers compared with high SES smokers has not previously been examined.Entities:
Keywords: Closed groups; GP; General Practitioner (family doctor); HCA; Health Care Assistant: undertakes routine care tasks such as: temperature and pulse rate, maintaining standards of hygiene, helping with patient mobility and emotional support, under the supervision of qualified nurses (NHS Scotland, 2010); Health disparities; IMD; Index of Multiple Deprivation (England); NCSCT; NHS; NRT; NS-SEC; National Centre for Smoking Cessation & Training; National Health Service (UK); National Statistics Socio-Economic Classification (UK) (in this analysis ‘retired’ were merged with ‘caring for home’ and ‘full time students’ were merged with ‘unclassified’ to differentiate socio-economic status from age); Nicotine Replacement Therapy; Open groups; PCT; Primary Care Trust (English health administration areas — there are ~150 PCTs serving a population of 56million people); SES; SSS; Smoking cessation; Socio-economic status; Specialist; Stop Smoking Services
Mesh:
Year: 2013 PMID: 23954946 PMCID: PMC3776925 DOI: 10.1016/j.addbeh.2013.07.010
Source DB: PubMed Journal: Addict Behav ISSN: 0306-4603 Impact factor: 3.913
Quit rates and multilevel modelling odds ratios for SES and SSS service type variables main effects and higher level variance.
| N | % | % Quit | Bivariate | Multivariate SES measured by eligibility for free prescriptions | Multivariate SES measured by NS-SEC | |
|---|---|---|---|---|---|---|
| Routine and manual | 37,768 | 28.5 | 37.3 | 1 | 1 | |
| Intermediate | 11,539 | 8.7 | 37.6 | 1.09 (1.04 to 1.14) | 1.10 (1.05 to 1.15) | |
| Managerial and professional | 21,893 | 16.5 | 39.9 | 1.20 (1.15 to 1.24) | 1.17 (1.12 to 1.21) | |
| Retired or home care | 10,203 | 7.7 | 33.9 | 0.89 (0.85 to 0.94) | 0.90 (0.86 to 0.95) | |
| Permanently sick | 10,166 | 7.7 | 29.3 | 0.72 (0.69 to 0.76) | 0.67 (0.64 to 0.71) | |
| Long-term unemployed | 21,132 | 15.9 | 28.1 | 0.67 (0.64 to 0.70) | 0.71 (0.68 to 0.74) | |
| In prison | 2038 | 1.5 | 42.1 | 1.09 (0.94 to 1.26) | 1.69 (1.45 to 1.97) | |
| Other | 17,847 | 13.5 | 28.8 | 0.75 (0.72 to 0.78) | 0.83 (0.79 to 0.87) | |
| Exempt | 65,710 | 49.6 | 31.9 | 1 | 1 | |
| Pays | 53,370 | 40.3 | 39.2 | 1.42 (1.39 to 1.46) | 1.38 (1.35 to 1.42) | |
| Unknown | 13,506 | 10.2 | 27.1 | 0.93 (0.88 to 0.97) | 0.98 (0.93 to 1.03) | |
| One-to-one | 104,556 | 78.9 | 33.9 | 1 | 1 | 1 |
| Drop-in clinic | 18,765 | 14.2 | 33.9 | 1.03 (0.96 to 1.09) | 0.98 (0.92 to 1.05) | 1.00 (0.94 to 1.07) |
| Open (rolling) group | 3844 | 2.9 | 50.8 | 1.44 (1.29 to 1.61) | 1.28 (1.14 to 1.43) | 1.26 (1.12 to 1.41) |
| Closed group | 2145 | 1.6 | 49.1 | 1.35 (1.20 to 1.52) | 1.20 (1.06 to 1.36) | 1.11 (0.98 to 1.26) |
| Other or missing | 3276 | 2.5 | 23.4 | 0.64 (0.57 to 0.71) | 0.59 (0.53 to 0.66) | 0.59 (0.53 to 0.65) |
| Specialist advisor | 40,234 | 30.3 | 38.0 | 1 | 1 | 1 |
| GP | 2640 | 2.0 | 35.9 | 0.61 (0.48 to 0.77) | 0.58 (0.46 to 0.73) | 0.59 (0.46 to 0.74) |
| Nurse | 13,095 | 9.9 | 29.1 | 0.72 (0.64 to 0.81) | 0.73 (0.64 to 0.82) | 0.73 (0.65 to 0.83) |
| HCA | 5604 | 4.2 | 34.6 | 0.88 (0.75 to 1.02) | 0.92 (0.79 to 1.07) | 0.92 (0.79 to 1.07) |
| Pharmacy | 13,731 | 10.4 | 32.2 | 0.86 (0.77 to 0.96) | 0.96 (0.86 to 1.07) | 0.96 (0.86 to 1.07) |
| Other or unknown | 57,282 | 43.2 | 33.4 | 0.85 (0.78 to 0.93) | 0.93 (0.84 to 1.02) | 0.92 (0.84 to 1.01) |
| Variance (95% CI) | Variance (95% CI) | |||||
| 0.19 (0.10 to 0.28) | 019 (0.10 to 0.28) | |||||
| Practitioner ID variance | 0.46 (0.43 to 0.49) | 0.45 (0.42 to 0.48) | ||||
Quit rates and multilevel modelling odds ratios and 95% CI for control variables in main effects models.
| N | % | % Quit | One fixed effect | Multivariate (prescriptions) | Multivariate (NS-SEC) | |
|---|---|---|---|---|---|---|
| Total (regression constant) | 132,586 | 100.0 | 34.4 | 0.14 (0.11 to 0.19) | 0.17 (0.13 to 0.23) | |
| 19–30 | 33,492 | 25.3 | 27.2 | 1 | 1 | 1 |
| 31–39 | 32,546 | 24.5 | 34.8 | 1.48 (1.43 to 1.54) | 1.44 (1.39 to 1.50) | 1.42 (1.37 to 1.48) |
| 40–48 | 35,857 | 27.0 | 37.1 | 1.65 (1.60 to 1.71) | 1.60 (1.54 to 1.66) | 1.60 (1.54 to 1.65) |
| 49–59 | 30,691 | 23.1 | 38.5 | 1.78 (1.72 to 1.84) | 1.75 (1.69 to 1.81) | 1.79 (1.73 to 1.86) |
| Female | 68,232 | 51.5 | 34.1 | 1 | 1 | 1 |
| Male | 64,354 | 48.5 | 34.7 | 1.02 (0.99 to 1.04) | 1.00 (0.97 to 1.02) | 1.02 (0.99 to 1.04) |
| Black, Asian, mixed, other | 10,511 | 7.9 | 30.7 | 1 | 1 | 1 |
| White | 116,998 | 88.2 | 34.9 | 1.16 (1.11 to 1.22) | 1.05 (1.00 to 1.11) | 1.07 (1.02 to 1.13) |
| Unknown | 5077 | 3.8 | 29.5 | 0.97 (0.89 to 1.05) | 0.97 (0.89 to 1.05) | 0.99 (0.91 to 1.07) |
| ≤ 30 | 27,312 | 20.6 | 31.6 | 1 | 1 | 1 |
| 31–60 | 27,174 | 20.5 | 37.9 | 1.36 (0.92 to 2.01) | 1.27 (0.83 to 1.96) | 1.24 (0.81 to 1.92) |
| 61–90 | 12,792 | 9.6 | 31.5 | 1.08 (0.70 to 1.68) | 1.07 (0.66 to 1.73) | 1.06 (0.66 to 1.72) |
| 91–120 | 41,837 | 31.6 | 37.4 | 1.47 (1.04 to 2.09) | 1.17 (0.80 to 1.72) | 1.16 (0.79 to 1.71) |
| 121 + (least deprived) | 23,471 | 17.7 | 29.6 | 1.37 (0.92 to 2.02) | 1.28 (0.83 to 1.96) | 1.26 (0.82 to 1.94) |
| July 2010 | 11,443 | 8.6 | 31.4 | 1 | 1 | 1 |
| Aug 2010 | 10,406 | 7.8 | 33.1 | 1.07 (1.01 to 1.14) | 1.05 (0.99 to 1.12) | 1.05 (0.99 to 1.12) |
| Sept 2010 | 11,176 | 8.4 | 34.6 | 1.17 (1.10 to 1.24) | 1.15 (1.08 to 1.22) | 1.15 (1.08 to 1.22) |
| Oct 2010 | 11,677 | 8.8 | 34.0 | 1.13 (1.07 to 1.20) | 1.09 (1.03 to 1.16) | 1.09 (1.03 to 1.16) |
| Nov 2010 | 10,046 | 7.6 | 30.9 | 0.96 (0.91 to 1.03) | 0.91 (0.86 to 0.97) | 0.91 (0.86 to 0.97) |
| Jan 2011 | 20,495 | 15.5 | 39.0 | 1.39 (1.32 to 1.46) | 1.36 (1.29 to 1.44) | 1.36 (1.29 to 1.44) |
| Feb 2011 | 16,844 | 12.7 | 36.8 | 1.26 (1.19 to 1.33) | 1.19 (1.13 to 1.26) | 1.19 (1.13 to 1.26) |
| March 2011 | 16,744 | 12.6 | 33.6 | 1.09 (1.03 to 1.15) | 1.03 (0.98 to 1.09) | 1.04 (0.98 to 1.10) |
| April 2011 | 12,840 | 9.7 | 33.4 | 1.09 (1.03 to 1.16) | 1.02 (0.96 to 1.09) | 1.03 (0.97 to 1.09) |
| May 2011 | 10,915 | 8.2 | 31.9 | 1.02 (0.96 to 1.08) | 1.00 (0.94 to 1.06) | 1.00 (0.94 to 1.06) |
| Episode 1 | 85,705 | 64.6 | 34.6 | 1 | 1 | 1 |
| Episode 2 | 27,106 | 20.4 | 33.7 | 1.00 (0.97 to 1.03) | 0.98 (0.95 to 1.01) | 0.98 (0.95 to 1.01) |
| Episode 3 | 10,706 | 8.1 | 33.8 | 1.01 (0.97 to 1.06) | 0.99 (0.94 to 1.04) | 0.98 (0.94 to 1.03) |
| Episode 4 or more | 9069 | 6.8 | 35.2 | 1.09 (1.04 to 1.15) | 1.06 (1.01 to 1.11) | 1.06 (1.01 to 1.12) |
| Single NRT | 29,126 | 22.0 | 25.1 | 1 | 1 | 1 |
| Combination NRT | 48,127 | 36.3 | 37.4 | 2.11 (2.03 to 2.19) | 2.09 (2.02 to 2.17) | 2.11 (2.04 to 2.19) |
| Zyban only | 910 | .7 | 31.9 | 1.57 (1.35 to 1.83) | 1.45 (1.25 to 1.69) | 1.45 (1.25 to 1.69) |
| Champix only | 37,995 | 28.7 | 42.3 | 2.48 (2.38 to 2.57) | 2.37 (2.28 to 2.47) | 2.38 (2.29 to 2.47) |
| Mixed NRT/Zyban/Champix | 3478 | 2.6 | 33.1 | 1.77 (1.63 to 1.92) | 1.71 (1.58 to 1.86) | 1.71 (1.58 to 1.86) |
| Missing or no medication | 12,950 | 9.8 | 21.2 | 0.78 (0.74 to 0.83) | 0.79 (0.74 to 0.84) | 0.78 (0.74 to 0.84) |
Uptake and quit rates by advisor type and SES.
| Uptake | Uptake by advisor type | CO validated quit at 4 weeks | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | Specialist advisor | GP | Nurse | HCA | Pharmacy | p | Specialist advisor | GP | Nurse | HCA | Pharmacy | p | ||
| P < .001 | P < .001 | ||||||||||||||
| Routine and manual | 21,716 | 58% | 4% | 17% | 7% | 14% | < .001 | 41% | 41% | 31% | 38% | 35% | < .001 | ||
| Intermediate | 6717 | 54% | 2% | 19% | 9% | 16% | < .001 | 39% | 41% | 35% | 38% | 35% | 0.017 | ||
| Managerial and professional | 12,632 | 52% | 4% | 18% | 7% | 20% | < .001 | 43% | 43% | 37% | 41% | 38% | < .001 | ||
| Retired or home care | 6097 | 56% | 3% | 18% | 8% | 15% | < .001 | 38% | 34% | 28% | 33% | 32% | < .001 | ||
| Permanently sick | 5874 | 64% | 3% | 14% | 6% | 14% | < .001 | 32% | 35% | 24% | 31% | 30% | 0.001 | ||
| Long-term unemployed | 11,406 | 52% | 3% | 16% | 8% | 21% | < .001 | 31% | 30% | 25% | 29% | 26% | < .001 | ||
| In prison | 987 | 72% | 0% | 1% | 7% | 20% | < .001 | 48% | 0% | 5% | 45% | 24% | NA | ||
| 65,429 | 56% | 3% | 17% | 7% | 17% | < .001 | 38% | 39% | 31% | 36% | 33% | <. | |||
| < .001 | P <. 001 | ||||||||||||||
| Exempt | 37,313 | 56% | 3% | 13% | 7% | 21% | < .001 | 35% | 33% | 27% | 31% | 30% | < .001 | ||
| Pays | 30,902 | 53% | 4% | 19% | 8% | 16% | < .001 | 43% | 41% | 34% | 38% | 36% | < .001 | ||
| < .001 | <. | ||||||||||||||
The ‘other/unknown’ category was not included in chi square analysis.
Uptake and quit rates by intervention type and SES.
| Uptake | Uptake by intervention type | CO validated quit at 4 weeks | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | One-to-one | Drop-in clinic | Open/rolling group | Closed group | P | One-to-one | Drop-in clinic | Open/rolling group | Closed group | Total | p | |
| < .001 | P < .001 | ||||||||||||
| Routine and manual | 36,793 | 80% | 15% | 4% | 2% | < .001 | 37% | 37% | 55% | 51% | < .001 | ||
| Intermediate | 11,211 | 80% | 16% | 2% | 2% | < .001 | 38% | 36% | 49% | 47% | < .001 | ||
| Managerial & professional | 21,455 | 80% | 15% | 3% | 2% | < .001 | 40% | 38% | 58% | 51% | < .001 | ||
| Retired or home care | 9944 | 80% | 16% | 4% | 1% | < .001 | 34% | 33% | 53% | 48% | < .001 | ||
| Sick or disabled and unable to work | 9881 | 80% | 15% | 4% | 1% | < .001 | 29% | 30% | 45% | 38% | < .001 | ||
| Never worked or long-term unemployed | 20,701 | 83% | 15% | 2% | 1% | < .001 | 28% | 27% | 35% | 33% | < .010 | ||
| In prison | 2014 | 71% | 12% | 3% | 14% | < .001 | 40% | 40% | 42% | 57% | < .001 | ||
| < .001 | <. | ||||||||||||
| < .001 | P <. 001 | ||||||||||||
| Exempt | 64,120 | 80% | 16% | 3% | 1% | < .001 | 32% | 31% | 47% | 44% | 32% | < .001 | |
| Pays | 52,073 | 81% | 14% | 3% | 2% | < .001 | 39% | 38% | 55% | 54% | 40% | < .001 | |
| < .001 | 35% | 34% | 51% | 50% | 35% | <. | |||||||
The ‘other/unknown’ category was not included in chi square analysis.
Multivariable, multilevel odds ratios (95% CI) for cross classified variables.
Also entered are SSS, advisor, age, gender, ethnicity, disadvantage in area covered by SSS, month quit-date set, number of treatment episodes, medication and advisor type (1a only), and intervention type (1b only).
Intervention type: reference category as main effects analysis: other category 0.79 (0.75 to 0.83).
Advisor type: reference category as main effects analysis: other category 0.87 (0.81 to 0.93).
Bold font significant interaction, light shade: significantly more likely to quit, dark shade significantly less likely to quit (p < .05).